-
InformationiCFO Information Booth How can we help?
-
EntrepreneurFLIPPOS
-
EntrepreneurThe Brain Surgery Group
-
EntrepreneurTAM-C Solutions
-
EntrepreneurCommerceBlitz
-
EntrepreneurPopticals
-
EntrepreneurKove CRAFT BREWED and COCKTAIL INSPIRED
-
EntrepreneurRicovr
-
EntrepreneurOberit
-
EntrepreneurWavetech Innovation for a Sustainable Future: Realizing the Full Potential of Every Battery
-
EntrepreneurAlex's Awesome Sourdough
-
EntrepreneurFirst Person Solutions
-
EntrepreneurCosmic Venture Partners
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Gaytri Kachroo!
Join us next time to meet Gaytri Kachroo!
About Arise BioPharma
Arise BioPharma Inc. (Arise) is a wholly owned subsidiary of Peptide Account LLC. Arise holds property rights to several late stage compounds targeting neuro-degenerative illnesses. It is poised to enter a high-value Phase 2/3 clinical study in an orphan indication, namely Progressive Multifocal Leukocencephalopathy (PML) with prior clinical evidence in a proof of concept Phase 2a study and Emergency INDs.